Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes.
Angela NebbiosoFabio ManzoMarco MiceliMariarosaria ConteLucrezia ManenteAlfonso BaldiAntonio De LucaDante RotiliSergio ValenteAntonello MaiAlessandro UsielloHinrich GronemeyerLucia AltucciPublished in: EMBO reports (2020)
Keyphrases